The clinical impact of the universal diagnosis of myocardial infarction

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 11, 2008, Pages 1485-1488

  Jaffe, Allan S ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Myocardial infarction; Troponin; Universal

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; LACTATE DEHYDROGENASE; TROPONIN;

ACUTE HEART INFARCTION; ASSAY; CLINICAL PRACTICE; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; ENZYME BLOOD LEVEL; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY DIAGNOSIS; LABORATORY TEST; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS;

BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; TROPONIN;

EID: 56549096027     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.296     Document Type: Conference Paper

References (24)

1. WHO Expert Committee on Cardiovascular Disease and Hypertension. Hypertension and coronary artery disease: classification and criteria for epidemiological studies. World Health Organ Tech Support Ser 1959;168:3-28.
2. Dolci A. Panteghini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 2006;369:179-87.
3. Anonymous. The pathological diagnosis of acute myocardial infarction: preliminary results of a WHO cooperative study. Bull World Health Organiz 1973;48:23-5.
4. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in 4 continents. Circulation 1994;90:583-612.
5. The Joint European Society of Cardiology/American College of Cardiology Committee: Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13;
6. J Am Coll Cardiol 2000;36:959-69.
7. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38;
8. Circulation 2007;116:2634-53;
9. J Am Coll Cardiol 2007;50:2173-95.
10. Apple FS, Wu AH, Jaffe AS. Implementation of the ESC/ACC guidelines for redefinition of myocardial infarction using cardiac troponin assays with special attention to clinical trial issues. Am Heart J 2002;144:981-6.
11. Morrow D, Cannon C, Jesse R, Newby L, Ravkilde J, Storrow A, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007;53:552-74.
12. Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Melanson S, et al. Prospective evaluation of the prognostic implications of low level elevation of cardiac troponin using a new highly-sensitive assay for cardiac troponin I: results from the Merlin TIMI 36 Trial. Circulation 2007;116:II-381 [Abstract 1790].
13. Lin JC, Apple FS, Murakami MM, Luepker RV. Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes. Clin Chem 2004;50:333-8.
14. Eggers KM, Oldgren J, Nordenskjold A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574-81.
15. MacRae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, et al. Assessing the requirement for the six-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem 2006;52:812-8.
16. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007;12:282-6.
17. Apple F, Murakami M, Pearce L, Herzog C. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
18. Wallace T, Abdullah S, Drazner M, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
19. Hsieh BP, Whooley MA, Schiller NB. The prevalence and prognostic value of cardiac troponin T elevation in ambulatory patients with stable coronary artery disease. JACC 2008;51:A378.
20. Jaffe AS. Chasing troponin, how low can you go if you can see the rise? JACC 2006:48:1763-4.
21. Martinez MW, Babuin L, Syed IS, Feng DL, Miller WL, Mathew V, et al. Myocardial infarction with normal coronary arteries: a role for MRI? Clin Chem 2007;53:995-6.
22. Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007;28:1242-9.
23. Marmor A, Geltman E, Schechtman K, Sobel B, Roberts R. Recurrent myocardial infarction: clinical predictors and prognostic implications. Circulation 1982;66:415-22.
24. Apple FS, Murakami MM. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. Clin Chem 2005;51:460-3.